Form 483

IDT Biologika GmbH Form 483, 2023-09-08

FDA issued a Form 483 to IDT Biologika GmbH on 2023-09-08 with 5 public-safe observations.

483· Form 483 issuedBiologics5 observations

IDT Biologika GmbH · Dessau-Rosslau, Germany · Issued September 8, 2023

Overview

  • 5 public-safe observations are available for this inspection.
  • 5 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

8 Sep 2023
21 CFR 211.194(a)(2)

Suitability of testing methods verified

Cited by Roger F Zabinski, Laurel A Beer

8 Sep 2023
21 CFR 211.25(a)

GMP Training Frequency

Cited by Roger F Zabinski, Laurel A Beer

8 Sep 2023
21 CFR 211.42(c)(10)(iv)

Environmental Monitoring System

Cited by Roger F Zabinski, Laurel A Beer

8 Sep 2023
21 CFR 211.68(b)

Backup data not assured as exact and complete

Cited by Roger F Zabinski, Laurel A Beer

8 Sep 2023
21 CFR 610.1

Tests prior to release

Cited by Roger F Zabinski, Laurel A Beer

Inspected site

IBIDT Biologika GmbHDessau-Rosslau, Germany

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.194(a)(2)Cited across public-safe Form 483 observations1x
21 CFR 211.25(a)Cited across public-safe Form 483 observations1x
21 CFR 211.42(c)(10)(iv)Cited across public-safe Form 483 observations1x
21 CFR 211.68(b)Cited across public-safe Form 483 observations1x
21 CFR 610.1Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 5 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere